Copyright
©The Author(s) 2023.
World J Gastrointest Endosc. Mar 16, 2023; 15(3): 177-190
Published online Mar 16, 2023. doi: 10.4253/wjge.v15.i3.177
Published online Mar 16, 2023. doi: 10.4253/wjge.v15.i3.177
Ref. | Country | Study type | Total patients | Mean age | Female gender (%) | Chemotherapy |
Sampath et al[23], 2016 | United States | Case-Control | 25 | 69.7 | 10 (40.0) | 19 (76) |
Hu et al[21], 2016 | China | RCT | 63 | 71.4 | 32 (50.8) | - |
Wu et al[26], 2017 | China | Case-Control | 71 | 57.9 | 28 (39.2) | 59 (83) |
Cui et al[25], 2017 | China | Case-Control | 39 | 64.7 | 17 (43.5) | 2 (5) |
Yang et al[22], 2018 | China | RCT | 65 | 63.2 | 32 (49.2) | - |
Bokemeyer et al[24], 2019 | Germany | Case-Control | 44 | 67 | - | 13 (30) |
- Citation: Rebhun J, Shin CM, Siddiqui UD, Villa E. Endoscopic biliary treatment of unresectable cholangiocarcinoma: A meta-analysis of survival outcomes and systematic review. World J Gastrointest Endosc 2023; 15(3): 177-190
- URL: https://www.wjgnet.com/1948-5190/full/v15/i3/177.htm
- DOI: https://dx.doi.org/10.4253/wjge.v15.i3.177